(Q33291373)

25 July 2017

The role of Janus Kinase 2 V617F mutation in extramedullary hematopoiesis of the spleen in neoplastic myeloid disorders (English)

1 reference

25 July 2017

0 references

Pin-Pen Hsieh

1

1 reference

25 July 2017

Randy J Olsen

2

1 reference

25 July 2017

Dennis P O'Malley

3

1 reference

25 July 2017

Sergej N Konoplev

4

1 reference

25 July 2017

Jerry W Hussong

5

1 reference

25 July 2017

Cherie H Dunphy

6

1 reference

25 July 2017

Sherrie L Perkins

7

1 reference

25 July 2017

Liang Cheng

8

1 reference

25 July 2017

Pei Lin

9

1 reference

25 July 2017

Chung-Che Chang

10

1 reference

25 July 2017

20 July 2007

1 reference

25 July 2017

1 reference

25 July 2017

20

1 reference

25 July 2017

9

1 reference

25 July 2017

929-935

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.3800826

25 July 2017

0 references

cites work

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

Hematopoiesis in the human spleen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

The pathogenesis of splenic extramedullary hematopoiesis in metastatic carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

Morphologic and immunohistochemical evaluation of splenic hematopoietic proliferations in neoplastic and benign disorders

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

Analysis of loss of heterozygosity and X chromosome inactivation in spleens with myeloproliferative disorders and acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

Extramedullary haemopoiesis in fetal and adult human spleen: a quantitative immunohistological study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

A gain-of-function mutation of JAK2 in myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

JAK2 (V617F) mutation in healthy individuals

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

JAK2 mutation in essential thrombocythaemia: clinical associations and long-term prognostic relevance

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

Role of tyrosine kinases and phosphatases in polycythemia vera.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

Constitutive activation of STAT5 and Bcl-xL overexpression can induce endogenous erythroid colony formation in human primary cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

Of JAKs, STATs, blind watchmakers, jeeps and trains

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

Signal transducers and activators of transcription 5 contributes to erythropoietin-mediated neuroprotection against hippocampal neuronal death after transient global cerebral ischemia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

Clinical correlates of splenic histopathology and splenic karyotype in myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

Molecular genetic alterations in the laser‐capture–microdissected stroma adjacent to bladder carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

C-erb-B2 (HER2/neu) expression in synovial sarcoma of the head and neck

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

BCL10 expression in ocular adnexal lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

JAK2 V617F in myeloid disorders: molecular diagnostic techniques and their clinical utility: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

Clinical, pathological and molecular features of the chronic myeloproliferative disorders: MPD 2005 and beyond

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

The JAK2 V617F tyrosine kinase mutation in myelodysplastic syndromes (MDS) developing myelofibrosis indicates the myeloproliferative nature in a subset of MDS patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

Mutational screen reveals a novel JAK2 mutation, L611S, in a child with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

Mutation studies in CD3+, CD19+ and CD34+ cell fractions in myeloproliferative disorders with homozygous JAK2(V617F) in granulocytes

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

The JAK2 V617F mutation in de novo acute myelogenous leukemias.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

V617F mutation in JAK2 is associated with poorer survival in idiopathic myelofibrosis.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

The presence of the JAK2 V617F mutation is associated with a higher haemoglobin and increased risk of thrombosis in essential thrombocythaemia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800826

7 January 2021

10.1038/MODPATHOL.3800826

Identifiers

DOI

1 reference

Dimensions Publication ID

25 July 2017

0 references

1 reference